vs
Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $20.6M, roughly 1.5× Entrada Therapeutics, Inc.). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -84.4%, a 92.5% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -65.2%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (7.0% CAGR vs 6.4%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
CHCT vs TRDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.5M | $20.6M |
| Net Profit | $2.5M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | — | -106.0% |
| Net Margin | 8.1% | -84.4% |
| Revenue YoY | 4.8% | -65.2% |
| Net Profit YoY | 60.2% | -173.8% |
| EPS (diluted) | — | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $31.5M | — | ||
| Q4 25 | $30.9M | — | ||
| Q3 25 | $31.1M | — | ||
| Q2 25 | $29.1M | — | ||
| Q1 25 | $30.1M | $20.6M | ||
| Q4 24 | $29.3M | $37.4M | ||
| Q3 24 | $29.6M | $19.6M | ||
| Q2 24 | $27.5M | $94.7M |
| Q1 26 | $2.5M | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $-12.6M | — | ||
| Q1 25 | $1.6M | $-17.3M | ||
| Q4 24 | $1.8M | $1.1M | ||
| Q3 24 | $1.7M | $-14.0M | ||
| Q2 24 | $-10.4M | $55.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | — | 56.4% |
| Q1 26 | 8.1% | — | ||
| Q4 25 | 46.6% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | -43.2% | — | ||
| Q1 25 | 5.3% | -84.4% | ||
| Q4 24 | 6.3% | 3.0% | ||
| Q3 24 | 5.9% | -71.7% | ||
| Q2 24 | -37.9% | 58.1% |
| Q1 26 | — | — | ||
| Q4 25 | $0.52 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.50 | — | ||
| Q1 25 | $0.03 | $-0.42 | ||
| Q4 24 | $0.04 | $-0.20 | ||
| Q3 24 | $0.04 | $-0.35 | ||
| Q2 24 | $-0.42 | $1.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $421.3M | $417.3M |
| Total Assets | $1.0B | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $2.6M | — | ||
| Q4 25 | $3.3M | — | ||
| Q3 25 | $3.4M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $2.3M | $67.8M | ||
| Q4 24 | $4.4M | $101.2M | ||
| Q3 24 | $2.8M | $78.0M | ||
| Q2 24 | $734.0K | $185.3M |
| Q1 26 | — | — | ||
| Q4 25 | $532.2M | — | ||
| Q3 25 | $530.1M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $496.0M | — | ||
| Q4 24 | $486.0M | — | ||
| Q3 24 | $473.7M | — | ||
| Q2 24 | $457.6M | — |
| Q1 26 | $421.3M | — | ||
| Q4 25 | $429.4M | — | ||
| Q3 25 | $426.8M | — | ||
| Q2 25 | $437.8M | — | ||
| Q1 25 | $461.3M | $417.3M | ||
| Q4 24 | $476.0M | $428.7M | ||
| Q3 24 | $477.2M | $422.4M | ||
| Q2 24 | $497.8M | $429.9M |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $990.8M | — | ||
| Q3 25 | $987.3M | — | ||
| Q2 25 | $966.3M | — | ||
| Q1 25 | $985.1M | $486.5M | ||
| Q4 24 | $992.6M | $526.3M | ||
| Q3 24 | $981.8M | $554.6M | ||
| Q2 24 | $983.2M | $582.0M |
| Q1 26 | — | — | ||
| Q4 25 | 1.24× | — | ||
| Q3 25 | 1.24× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.92× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-38.5M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -192.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $56.4M | — | ||
| Q3 25 | $12.7M | — | ||
| Q2 25 | $13.8M | — | ||
| Q1 25 | $14.4M | $-38.5M | ||
| Q4 24 | $58.9M | $-31.6M | ||
| Q3 24 | $13.8M | $-24.3M | ||
| Q2 24 | $16.7M | $39.8M |
| Q1 26 | — | — | ||
| Q4 25 | $35.9M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.7M | $-39.7M | ||
| Q4 24 | $34.2M | $-32.2M | ||
| Q3 24 | $6.7M | $-24.9M | ||
| Q2 24 | $9.5M | $38.8M |
| Q1 26 | — | — | ||
| Q4 25 | 116.0% | — | ||
| Q3 25 | 24.6% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 32.3% | -192.9% | ||
| Q4 24 | 116.9% | -86.2% | ||
| Q3 24 | 22.5% | -127.3% | ||
| Q2 24 | 34.7% | 41.0% |
| Q1 26 | — | — | ||
| Q4 25 | 66.3% | — | ||
| Q3 25 | 16.3% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | 15.6% | 5.6% | ||
| Q4 24 | 84.1% | 1.7% | ||
| Q3 24 | 24.2% | 3.3% | ||
| Q2 24 | 26.1% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.91× | — | ||
| Q3 25 | 7.76× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.06× | — | ||
| Q4 24 | 32.14× | -27.94× | ||
| Q3 24 | 7.92× | — | ||
| Q2 24 | — | 0.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
